Figure 5.
Figure 5. Pre–β rearrangement proliferation of T-cell progenitors from FL, FB, and FT. (A) IL-7R+ FL cells, IL-7R+ FB cells, and FcR– FT cells from 12-dpc Rag2–/– fetuses as well as CD44+CD25– FT cells and CD44+CD25+ FT cells from 14-dpc Rag2–/– fetuses were individually cultured with a dGuo-treated FT lobe under HOS conditions for 10 days. Numbers of CD25+ cells generated in each of the 5 to 10 clones are shown. (B) IL-7R+ FB cells (12 dpc) and CD44+CD25+ FT cells (14 dpc) from normal strain of mice (B6) were individually cultured under HOS conditions for 12 days. Genomic DNA was prepared from T cells generated in each well. Cells from a dGuo-treated lobe that was not seeded with a progenitor were used as a negative control. Each sample (equivalent to 750 cells) was PCR amplified using primers for Dβ1-Jβ1.6, Dβ2-Jβ2.6, or Dβ1-Jβ2.6, the locations of which are schematically shown under the figure.

Pre–β rearrangement proliferation of T-cell progenitors from FL, FB, and FT. (A) IL-7R+ FL cells, IL-7R+ FB cells, and FcR FT cells from 12-dpc Rag2–/– fetuses as well as CD44+CD25 FT cells and CD44+CD25+ FT cells from 14-dpc Rag2–/– fetuses were individually cultured with a dGuo-treated FT lobe under HOS conditions for 10 days. Numbers of CD25+ cells generated in each of the 5 to 10 clones are shown. (B) IL-7R+ FB cells (12 dpc) and CD44+CD25+ FT cells (14 dpc) from normal strain of mice (B6) were individually cultured under HOS conditions for 12 days. Genomic DNA was prepared from T cells generated in each well. Cells from a dGuo-treated lobe that was not seeded with a progenitor were used as a negative control. Each sample (equivalent to 750 cells) was PCR amplified using primers for Dβ1-Jβ1.6, Dβ2-Jβ2.6, or Dβ1-Jβ2.6, the locations of which are schematically shown under the figure.

Close Modal

or Create an Account

Close Modal
Close Modal